協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/06/09 | 1,975 | 1,983 | 1,952 | 1,966 | -24 | -1.2% | 832,300 |
2016/06/08 | 1,959 | 1,990 | 1,947 | 1,990 | +25 | +1.3% | 760,900 |
2016/06/07 | 1,951 | 1,987 | 1,940 | 1,965 | +10 | +0.5% | 1,157,600 |
2016/06/06 | 1,925 | 1,958 | 1,916 | 1,955 | +4 | +0.2% | 1,059,400 |
2016/06/03 | 1,939 | 1,957 | 1,929 | 1,951 | +17 | +0.9% | 933,200 |
2016/06/02 | 1,943 | 1,950 | 1,920 | 1,934 | -40 | -2% | 1,420,000 |
2016/06/01 | 1,997 | 2,011 | 1,966 | 1,974 | -46 | -2.3% | 1,674,100 |
2016/05/31 | 2,055 | 2,055 | 1,997 | 2,020 | -37 | -1.8% | 3,316,000 |
2016/05/30 | 2,029 | 2,057 | 1,988 | 2,057 | +28 | +1.4% | 971,600 |
2016/05/27 | 2,049 | 2,063 | 2,025 | 2,029 | -25 | -1.2% | 788,300 |
2016/05/26 | 2,050 | 2,069 | 2,018 | 2,054 | +12 | +0.6% | 1,361,400 |
2016/05/25 | 2,068 | 2,080 | 2,036 | 2,042 | -5 | -0.2% | 1,065,100 |
2016/05/24 | 2,050 | 2,060 | 2,032 | 2,047 | -8 | -0.4% | 1,297,600 |
2016/05/23 | 2,069 | 2,080 | 2,032 | 2,055 | -15 | -0.7% | 1,042,500 |
2016/05/20 | 2,050 | 2,074 | 2,039 | 2,070 | +37 | +1.8% | 1,508,400 |
2016/05/19 | 2,031 | 2,047 | 2,012 | 2,033 | +2 | +0.1% | 939,100 |
2016/05/18 | 2,003 | 2,047 | 2,001 | 2,031 | +9 | +0.4% | 1,215,000 |
2016/05/17 | 1,995 | 2,025 | 1,976 | 2,022 | +40 | +2% | 1,082,900 |
2016/05/16 | 2,007 | 2,020 | 1,981 | 1,982 | -45 | -2.2% | 969,200 |
2016/05/13 | 1,998 | 2,039 | 1,980 | 2,027 | +39 | +2% | 1,657,100 |
2016/05/12 | 2,006 | 2,012 | 1,968 | 1,988 | -26 | -1.3% | 939,200 |
2016/05/11 | 2,019 | 2,025 | 1,977 | 2,014 | -12 | -0.6% | 876,000 |
2016/05/10 | 1,959 | 2,026 | 1,950 | 2,026 | +78 | +4% | 1,662,900 |
2016/05/09 | 1,933 | 1,973 | 1,918 | 1,948 | +55 | +2.9% | 1,266,300 |
2016/05/06 | 1,894 | 1,915 | 1,869 | 1,893 | -20 | -1% | 1,708,000 |
2016/05/02 | 1,900 | 1,918 | 1,876 | 1,913 | -71 | -3.6% | 1,660,900 |
2016/04/28 | 2,088 | 2,098 | 1,970 | 1,984 | -28 | -1.4% | 2,612,500 |
2016/04/27 | 2,015 | 2,069 | 1,960 | 2,012 | +13 | +0.7% | 1,976,500 |
2016/04/26 | 1,999 | 2,006 | 1,967 | 1,999 | -4 | -0.2% | 1,045,200 |
2016/04/25 | 2,029 | 2,035 | 1,989 | 2,003 | -13 | -0.6% | 1,221,200 |
2016/04/22 | 1,994 | 2,017 | 1,970 | 2,016 | +26 | +1.3% | 1,555,400 |
2016/04/21 | 1,989 | 2,030 | 1,963 | 1,990 | +60 | +3.1% | 2,092,500 |
2016/04/20 | 1,936 | 1,964 | 1,917 | 1,930 | +5 | +0.3% | 1,113,100 |
2016/04/19 | 1,920 | 1,940 | 1,910 | 1,925 | +40 | +2.1% | 1,301,500 |
2016/04/18 | 1,895 | 1,919 | 1,881 | 1,885 | -73 | -3.7% | 1,548,100 |
2016/04/15 | 1,921 | 1,980 | 1,896 | 1,958 | +37 | +1.9% | 2,110,800 |
2016/04/14 | 1,857 | 1,924 | 1,850 | 1,921 | +112 | +6.2% | 2,305,400 |
2016/04/13 | 1,759 | 1,815 | 1,748 | 1,809 | +59 | +3.4% | 1,221,500 |
2016/04/12 | 1,750 | 1,788 | 1,748 | 1,750 | -24 | -1.4% | 1,176,500 |
2016/04/11 | 1,785 | 1,791 | 1,747 | 1,774 | -36 | -2% | 1,254,100 |
2016/04/08 | 1,759 | 1,837 | 1,734 | 1,810 | +42 | +2.4% | 2,165,900 |
2016/04/07 | 1,696 | 1,771 | 1,694 | 1,768 | +86 | +5.1% | 1,901,500 |
2016/04/06 | 1,692 | 1,697 | 1,658 | 1,682 | -11 | -0.6% | 1,030,400 |
2016/04/05 | 1,726 | 1,747 | 1,686 | 1,693 | -12 | -0.7% | 1,179,000 |
2016/04/04 | 1,679 | 1,728 | 1,666 | 1,705 | +2 | +0.1% | 1,219,900 |
2016/04/01 | 1,796 | 1,798 | 1,696 | 1,703 | -93 | -5.2% | 1,494,300 |
2016/03/31 | 1,828 | 1,829 | 1,796 | 1,796 | -19 | -1% | 1,246,200 |
2016/03/30 | 1,836 | 1,843 | 1,814 | 1,815 | ±0 | ±0% | 1,148,600 |
2016/03/29 | 1,799 | 1,835 | 1,798 | 1,815 | +4 | +0.2% | 958,100 |
2016/03/28 | 1,797 | 1,822 | 1,788 | 1,811 | +28 | +1.6% | 1,109,600 |
2251~
2300
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム